Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132472) titled 'Evaluation of the Impact of Different Glucocorticoid Bridge Regimens on the Efficacy of Methotrexate in Treating Pulmonary Saicoidosis: A Prospective, Multicenter, Randomized Controlled Study' on Sept. 15.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Sixth Medical Center of Chinese PLA General Hospital
Condition:
Pulmonary saicoidosis
Intervention:
Methotrexate group:Methotrexate group: Treatment with oral methotrexate tablets alone. The initial dose of methotrexate tablets is 5-15 mg/week. Depending on efficacy and tolerability, the dose may be gradually adjusted after 8 w...